Distridenta SRL
Distridenta reported total assets of 38,729 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of Distridenta shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -18 % Total assets -9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Distridenta's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 29 May 2024
- Year ended 31 Dec 2022filed on 08 Jun 2023
- Year ended 31 Dec 2021filed on 21 Jun 2022
Distridenta's financial analysis
- Solvency89.6%sector median: 33.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Distridenta
Distridenta's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0473.717.811
- VAT number
- BE0473717811
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 05 Jan 2001
- Registered office
- 1120 Brussels
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Distridenta (SRL) has been based in Brussels since 2001, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 2,918 € and equity of 34,706 €; its revenue is not published. Its solvency stands at 89.6%, above the median of its sector (33.7%).
Companies similar to Distridenta
Companies in the same business, of comparable size and area, outside its group.
- Honeypatch Manufacture of pharmaceutical preparations Liège · balance sheet 330,409 €
- Adocs Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet 717,403 €
- Distriphar Wholesale of pharmaceutical and medical goods Brussels · balance sheet €1.09m
- Virilab Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 129,924 €
- AM4Dentists Wholesale of pharmaceutical and medical goods Ostend · balance sheet 116,737 €
- Medident Wholesale of pharmaceutical and medical goods Ronse · balance sheet 185,879 €
- MegaGen BeLux Wholesale of pharmaceutical and medical goods Brussels · balance sheet 100,159 €
- A - Medica Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 105,140 €
Frequently asked questions about Distridenta
What is the revenue of Distridenta?
Distridenta files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Distridenta?
In Belgium, the VAT number is the company number prefixed with BE: BE0473717811 for Distridenta, if the company is VAT-registered. Its company number (CBE) is 0473.717.811.
Where is the registered office of Distridenta?
According to the CBE register, the registered office of Distridenta is in 1120 Brussels.
What is the equity of Distridenta?
At the close of the 2025 financial year, the equity of Distridenta amounts to 34,706 €, a solvency of 89.6% of total assets.
Who manages Distridenta?
The register lists 1 active mandates at Distridenta. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Distridenta
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →